ICPT
Intercept Pharmaceuticals, Inc.
ICPT
ICPT
Delisted
ICPT was delisted on the 7th of November, 2023.
188 hedge funds and large institutions have $1.6B invested in Intercept Pharmaceuticals, Inc. in 2020 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 56 increasing their positions, 71 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
188
Holders Change
-26
Holders Change %
-12.15%
% of All Funds
4.15%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
26
Increased
56
Reduced
71
Closed
48
Calls
$79.6M
Puts
$79.9M
Net Calls
-$332K
Net Calls Change
+$49.4M
Top Buyers
| 1 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
+$18.6M |
| 2 |
Renaissance Technologies
New York
|
+$13.5M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$10.7M |
| 4 |
Barclays
London,
United Kingdom
|
+$10.6M |
| 5 |
Two Sigma Advisers
New York
|
+$9.27M |
Top Sellers
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$97M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$33.8M |
| 3 |
Jennison Associates
New York
|
-$20.9M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
-$14.1M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$12.4M |
